192 related articles for article (PubMed ID: 25543165)
1. Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells.
Wang Y; Han E; Xing Q; Yan J; Arrington A; Wang C; Tully D; Kowolik CM; Lu DM; Frankel PH; Zhai J; Wen W; Horne D; Yip MLR; Yim JH
Cancer Lett; 2015 Mar; 358(2):170-179. PubMed ID: 25543165
[TBL] [Abstract][Full Text] [Related]
2. ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway.
Li Y; Tao L; Zuo Z; Zhou Y; Qian X; Lin Y; Jie H; Liu C; Li Z; Zhang H; Zhang H; Cen X; Yang S; Zhao Y
Cancer Lett; 2019 Jul; 454():179-190. PubMed ID: 30978443
[TBL] [Abstract][Full Text] [Related]
3. Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas.
Snijders AM; Liu Y; Su L; Huang Y; Mao JH
Oncotarget; 2015 Dec; 6(42):44794-805. PubMed ID: 26575021
[TBL] [Abstract][Full Text] [Related]
4. DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways.
Du F; Sun L; Chu Y; Li T; Lei C; Wang X; Jiang M; Min Y; Lu Y; Zhao X; Nie Y; Fan D
Cancer Commun (Lond); 2018 Jul; 38(1):45. PubMed ID: 29976242
[TBL] [Abstract][Full Text] [Related]
5. PML nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4.
Salsman J; Stathakis A; Parker E; Chung D; Anthes LE; Koskowich KL; Lahsaee S; Gaston D; Kukurba KR; Smith KS; Chute IC; Léger D; Frost LD; Montgomery SB; Lewis SM; Eskiw C; Dellaire G
Sci Rep; 2017 Mar; 7():45038. PubMed ID: 28332630
[TBL] [Abstract][Full Text] [Related]
6. Baicalein induces autophagic cell death through AMPK/ULK1 activation and downregulation of mTORC1 complex components in human cancer cells.
Aryal P; Kim K; Park PH; Ham S; Cho J; Song K
FEBS J; 2014 Oct; 281(20):4644-58. PubMed ID: 25132405
[TBL] [Abstract][Full Text] [Related]
7. Baicalein increases the expression and reciprocal interplay of RUNX3 and FOXO3a through crosstalk of AMPKα and MEK/ERK1/2 signaling pathways in human non-small cell lung cancer cells.
Zheng F; Wu J; Zhao S; Luo Q; Tang Q; Yang L; Li L; Wu W; Hann SS
J Exp Clin Cancer Res; 2015 May; 34(1):41. PubMed ID: 25948105
[TBL] [Abstract][Full Text] [Related]
8. The m
Zhang Y; Liu X; Wang Y; Lai S; Wang Z; Yang Y; Liu W; Wang H; Tang B
Mol Cancer; 2022 Sep; 21(1):174. PubMed ID: 36056355
[TBL] [Abstract][Full Text] [Related]
9. Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/AKT/mTOR pathway.
Guo Z; Hu X; Xing Z; Xing R; Lv R; Cheng X; Su J; Zhou Z; Xu Z; Nilsson S; Liu Z
Mol Cell Biochem; 2015 Aug; 406(1-2):111-9. PubMed ID: 25957503
[TBL] [Abstract][Full Text] [Related]
10. Regulation of bone formation by baicalein via the mTORC1 pathway.
Li SF; Tang JJ; Chen J; Zhang P; Wang T; Chen TY; Yan B; Huang B; Wang L; Huang MJ; Zhang ZM; Jin DD
Drug Des Devel Ther; 2015; 9():5169-83. PubMed ID: 26392752
[TBL] [Abstract][Full Text] [Related]
11. In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies.
Pinto JA; Rolfo C; Raez LE; Prado A; Araujo JM; Bravo L; Fajardo W; Morante ZD; Aguilar A; Neciosup SP; Mas LA; Bretel D; Balko JM; Gomez HL
Sci Rep; 2017 May; 7(1):1526. PubMed ID: 28484222
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor cell growth, proliferation and migration by X-387, a novel active-site inhibitor of mTOR.
Chen SM; Liu JL; Wang X; Liang C; Ding J; Meng LH
Biochem Pharmacol; 2012 May; 83(9):1183-94. PubMed ID: 22305748
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of SIRT1/2 upregulates HSPA5 acetylation and induces pro-survival autophagy via ATF4-DDIT4-mTORC1 axis in human lung cancer cells.
Mu N; Lei Y; Wang Y; Wang Y; Duan Q; Ma G; Liu X; Su L
Apoptosis; 2019 Oct; 24(9-10):798-811. PubMed ID: 31321634
[TBL] [Abstract][Full Text] [Related]
14. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.
Zhang Y; Xu S; Lin J; Yao G; Han Z; Liang B; Zou Z; Chen Z; Song Q; Dai Y; Gao T; Liu A; Bai X
Breast Cancer Res Treat; 2012 Nov; 136(2):379-88. PubMed ID: 23053656
[TBL] [Abstract][Full Text] [Related]
15. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
16. The anti-metastatic effect of baicalein on colorectal cancer.
Chai Y; Xu J; Yan B
Oncol Rep; 2017 Apr; 37(4):2317-2323. PubMed ID: 28259937
[TBL] [Abstract][Full Text] [Related]
17. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
18. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
19. Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo.
Cathcart MC; Useckaite Z; Drakeford C; Semik V; Lysaght J; Gately K; O'Byrne KJ; Pidgeon GP
BMC Cancer; 2016 Sep; 16(1):707. PubMed ID: 27586635
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin regulates the proliferation of Huh7, a hepatocellular carcinoma cell line, by up-regulating p53 expression.
Kwon S; Jeon JS; Ahn C; Sung JS; Choi I
Biochem Biophys Res Commun; 2016 Oct; 479(1):74-9. PubMed ID: 27616194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]